This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Manne, U. Articles by Grizzle, W. E. Search for Related Content PubMed PubMed Citation Articles by Manne, U. Articles by Grizzle, W. E.

Prognostic Significance of p27^kip-1 Expression in Colorectal Adenocarcinomas Is Associated with Tumor Stage

¹ Department of Pathology and ² Biostatistics Unit of Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama

Purpose: Although the decreased expression of p27^kip-1, a cyclin-dependent kinase inhibitor, has been correlated with advanced tumor stage and short survival of patients with colorectal adenocarcinomas (CRCs), its prognostic value based on the tumor site, tumor stage, and patient ethnicity was not assessed. Therefore, in this study, we investigated whether the prognostic value of p27^kip-1 expression varies with the tumor site, tumor stage and patient ethnicity.

Experimental Design: We evaluated 206 (85 African Americans and 121 Caucasians) archival tissue specimens of first primary CRCs for immunohistochemical expression of p27^kip-1, and its prognostic significance was analyzed using univariate Kaplan-Meier and multivariate Cox regression survival methods.

Results: Although, similar proportion of CRCs with decreased p27^kip-1 expression was observed in all stages (range, 26–36%), the decreased p27^kip-1 expression has been shown as a marker of poor prognosis only for patients with stage III tumors both in univariate (log-rank test, P = 0.014) and multivariate (hazard ratio = 3.2, 95% confidence interval = 1.3–7.7; P = 0.01) survival analyses. The decreased expression of p27^kip-1 was associated with a high histologic grade (P = 0.016) in stage II CRCs, and with distal tumors (P = 0.001), tumor invasion (P = 0.044), and with local recurrence (P = 0.008) in stage III CRCs.

Conclusions: No prognostic significance was found for p27^kip-1 expression in stages I, II, or IV CRCs, and its prognostic value was not associated with either ethnicity or tumor location. These studies suggest that decreased expression of p27^kip-1 is an indicator of poor prognosis and aids in identifying a subset of patients with aggressive forms of stage III CRCs.

This article has been cited by other articles:

				S. Ogino, K. Shima, K. Nosho, N. Irahara, Y. Baba, B. M. Wolpin, E. L. Giovannucci, J. A. Meyerhardt, and C. S. Fuchs A Cohort Study of p27 Localization in Colon Cancer, Body Mass Index, and Patient Survival Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1849 - 1858. [Abstract] [Full Text] [PDF]

				M. S. Lyall, S. R. Dundas, S. Curran, and G. I. Murray Profiling Markers of Prognosis in Colorectal Cancer Clin. Cancer Res., February 15, 2006; 12(4): 1184 - 1191. [Abstract] [Full Text] [PDF]